TTK HEALTHCARE
Back to Cashflow Statement
|
TTK HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-22 Cr | ₹-12 Cr | ₹-10 Cr | ₹-17 Cr | ₹-10 Cr |
What is the latest Cash Flow from Financing Activities ratio of TTK HEALTHCARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-22 Cr |
Mar2023 | ₹-12 Cr |
Mar2022 | ₹-10 Cr |
Mar2021 | ₹-17 Cr |
Mar2020 | ₹-10 Cr |
How is Cash Flow from Financing Activities of TTK HEALTHCARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹-12 Cr | Negative | |
Mar2022 | ₹-10 Cr | Negative | |
Mar2021 | ₹-17 Cr | Negative | |
Mar2020 | ₹-10 Cr | - |
Compare Cash Flow from Financing Activities of peers of TTK HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TTK HEALTHCARE | ₹1,921.2 Cr | -4% | -10.3% | 0.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,143.0 Cr | -1.2% | 0.9% | 41.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,578.0 Cr | -3.7% | -1.8% | 46.1% | Stock Analytics | |
CIPLA | ₹120,185.0 Cr | -1.5% | 2.2% | 16.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,450.0 Cr | 1.4% | 10.6% | 17.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,569.0 Cr | 3.5% | 3.6% | 37.4% | Stock Analytics |
TTK HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TTK HEALTHCARE | -4% |
-10.3% |
0.9% |
SENSEX | -2.9% |
-4.8% |
8% |
You may also like the below Video Courses